Lomotil and Abdominal pain - a phase IV clinical study of FDA data
Summary:
Abdominal pain is reported as a side effect among people who take Lomotil (atropine sulfate; diphenoxylate hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humira, and have Pain.
The phase IV clinical study analyzes which people have Abdominal pain when taking Lomotil. It is created by eHealthMe based on reports of 18,891 people who have side effects when taking Lomotil from the FDA, and is updated regularly.
What is Lomotil?
Lomotil has active ingredients of atropine sulfate; diphenoxylate hydrochloride. It is often used in diarrhea. eHealthMe is studying from 19,184 Lomotil users. Check the latest studies of Lomotil.
What is Abdominal pain?
Abdominal pain is found to be associated with 3,237 drugs and 5,740 conditions by eHealthMe. Check the latest studies of Abdominal pain.
18,891 people reported to have side effects when taking Lomotil.
Among them, 1,063 people (5.63%) have Abdominal pain.
Among these 1,063 people:
How long have people been on Lomotil when they have Abdominal pain? *
What is the gender of people who have Abdominal pain when taking Lomotil? *
What is the age of people who have Abdominal pain when taking Lomotil? *
What are other drugs people take besides Lomotil? *
What are other side effects people have besides Abdominal pain? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lomotil and have Abdominal pain?
- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lomotil:
- Lomotil (19,184 reports)
Abdominal pain treatments and more:
- Abdominal pain (286,410 reports)
How severe was Abdominal pain and when was it recovered:
Expand to all the drugs that have ingredients of atropine sulfate; diphenoxylate hydrochloride:
- Abdominal pain and drugs with ingredients of atropine sulfate; diphenoxylate hydrochloride (1,562 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lomotil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abdominal pain:
- Abdominal pain (3,237 drugs)
Browse all the conditions that are associated with Abdominal pain:
- Abdominal pain (5,740 conditions)
Related publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
How the study uses the data?
The study uses data from the FDA. It is based on atropine sulfate; diphenoxylate hydrochloride (the active ingredients of Lomotil) and Lomotil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Eszopiclone and Can'T Sleep for Women aged 50-59 - now
- Eszopiclone and Agrypnia for Women aged 50-59 - a second ago
- Eszopiclone and Insomnia Concerns for Women aged 50-59 - a second ago
- Eszopiclone and Difficulty Falling Asleep for Women aged 50-59 - a second ago
- Eszopiclone and Sleeplessness for Women aged 50-59 - 2 seconds ago
- Eszopiclone and Inability To Sleep for Women aged 50-59 - 2 seconds ago
- Eszopiclone and Sleeping for Women aged 50-59 - 2 seconds ago
- Eszopiclone and Cannot Sleep for Women aged 50-59 - 2 seconds ago
- Eszopiclone and Sleep Aid for Women aged 50-59 - 3 seconds ago
- Eszopiclone and Insomnolence for Women aged 50-59 - 3 seconds ago